Fig. 1: CONSORT flow diagram. | Nature Medicine

Fig. 1: CONSORT flow diagram.

From: Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Fig. 1

Flow diagram depicts the disposition of patients throughout the phases of the study, including screening, neoadjuvant treatment and surgical resection. Reasons for screen failures, failure to complete planned neoadjuvant regimen and surgery not performed are shown. aEight patients required CT dose reduction. bSeven patients required CT dose reduction, and four patients required platinum agent change.

Back to article page